1. Home
  2. HFWA vs COLL Comparison

HFWA vs COLL Comparison

Compare HFWA & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Financial Corporation

HFWA

Heritage Financial Corporation

HOLD

Current Price

$29.66

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$35.36

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFWA
COLL
Founded
1927
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
HFWA
COLL
Price
$29.66
$35.36
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$30.50
$51.40
AVG Volume (30 Days)
397.9K
342.4K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.53%
N/A
EPS Growth
58.06
N/A
EPS
0.48
0.40
Revenue
N/A
$780,567,000.00
Revenue This Year
$45.85
$8.01
Revenue Next Year
$7.83
N/A
P/E Ratio
$61.54
$90.20
Revenue Growth
N/A
23.62
52 Week Low
$21.32
$29.70
52 Week High
$31.25
$50.79

Technical Indicators

Market Signals
Indicator
HFWA
COLL
Relative Strength Index (RSI) 48.27 45.76
Support Level $28.87 $33.93
Resistance Level $30.92 $35.76
Average True Range (ATR) 0.74 1.35
MACD -0.16 -0.10
Stochastic Oscillator 21.06 21.89

Price Performance

Historical Comparison
HFWA
COLL

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company, through its subsidiary, provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as non-interest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: